Cargando…

Selection, Expansion, and Unique Pretreatment of Allogeneic Human Natural Killer Cells with Anti-CD38 Monoclonal Antibody for Efficient Multiple Myeloma Treatment

Cellular immunotherapy is becoming a new pillar in cancer treatment after recent striking results in different clinical trials with chimeric antigen receptor T cells. However, this innovative therapy is not exempt from challenges such as off-tumor toxicity, tumor recurrence in heterogeneous tumors,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Motais, Benjamin, Charvátová, Sandra, Walek, Zuzana, Hrdinka, Matouš, Smolarczyk, Ryszard, Cichoń, Tomasz, Czapla, Justyna, Giebel, Sebastian, Šimíček, Michal, Jelínek, Tomáš, Ševčíková, Tereza, Sobotka, Jiří, Kořístek, Zdeněk, Hájek, Roman, Bagó, Juli R.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8143171/ https://www.ncbi.nlm.nih.gov/pubmed/33919155 http://dx.doi.org/10.3390/cells10050967

Ejemplares similares

A Bird’s-Eye View of Cell Sources for Cell-Based Therapies in Blood Cancers
por: Motais, Benjamin, et al.
Publicado: (2020)

Novel Local “Off-the-Shelf” Immunotherapy for the Treatment of Myeloma Bone Disease
por: Charvátová, Sandra, et al.
Publicado: (2023)

Intercellular Mitochondrial Transfer in the Tumor Microenvironment
por: Sahinbegovic, Hana, et al.
Publicado: (2020)

Tuning CARs: recent advances in modulating chimeric antigen receptor (CAR) T cell activity for improved safety, efficacy, and flexibility
por: Celichowski, Piotr, et al.
Publicado: (2023)

P805: EXTRAMEDULLARY MULTIPLE MYELOMA: MOLECULAR PATHOGENESIS AND NOVEL THERAPEUTIC TARGETS
por: Zihala, David, et al.
Publicado: (2023)

The deubiquitinase OTUD1 regulates immunoglobulin production and proteasome inhibitor sensitivity in multiple myeloma
por: Vdovin, Alexander, et al.
Publicado: (2022)

PB2397: TRANSCRIPTOME ANALYSIS OF DIFFUSE LARGE B-CELL LYMPHOMA CELLS EXPRESSING MYD88 L265P REVEALS CD44, LGALS3, NFKBIZ AND BATF AS DOWNSTREAM TARGETS OF ONCOGENIC NF-ΚB SIGNALING.
por: Turi, Marcello, et al.
Publicado: (2023)

Transcriptome Analysis of Diffuse Large B-Cell Lymphoma Cells Inducibly Expressing MyD88 L265P Mutation Identifies Upregulated CD44, LGALS3, NFKBIZ, and BATF as Downstream Targets of Oncogenic NF-κB Signaling
por: Turi, Marcello, et al.
Publicado: (2023)

Natural Killer Cells in the Malignant Niche of Multiple Myeloma
por: Venglar, Ondrej, et al.
Publicado: (2022)

Mutation landscape of multiple myeloma measurable residual disease: identification of targets for precision medicine
por: Zátopková, Martina, et al.
Publicado: (2022)

Current applications of multiparameter flow cytometry in plasma cell disorders
por: Jelinek, T, et al.
Publicado: (2017)

Current applications of multiparameter flow cytometry in plasma cell disorders
por: Jelinek, T, et al.
Publicado: (2018)

Biobanking strategy and sample preprocessing for integrative research in monoclonal gammopathies
por: Ševčíková, T, et al.
Publicado: (2017)

Length-Dependent Translation Efficiency of ER-Destined Proteins
por: Sahinbegovic, Hana, et al.
Publicado: (2023)

Combined Tumor Cell-Based Vaccination and Interleukin-12 Gene Therapy Polarizes the Tumor Microenvironment in Mice
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2015)

More Than 2% of Circulating Tumor Plasma Cells Defines Plasma Cell Leukemia–Like Multiple Myeloma
por: Jelinek, Tomas, et al.
Publicado: (2023)

Promising Immunotherapeutic Modalities for B-Cell Lymphoproliferative Disorders
por: Mihályová, Jana, et al.
Publicado: (2021)

The Effect of Radiotherapy on Cell Survival and Inflammatory Cytokine and Chemokine Secretion in a Co-Culture Model of Head and Neck Squamous Cell Carcinoma and Normal Cells
por: Matuszczak, Sybilla, et al.
Publicado: (2023)

Antitumor effect of anti-vascular therapy with STING agonist depends on the tumor microenvironment context
por: Czapla, Justyna, et al.
Publicado: (2023)

Brachytherapy in a Single Dose of 10Gy as an “in situ” Vaccination
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2020)

The Proper Administration Sequence of Radiotherapy and Anti-Vascular Agent—DMXAA Is Essential to Inhibit the Growth of Melanoma Tumors
por: Drzyzga, Alina, et al.
Publicado: (2021)

Newly designed 11-gene panel reveals first case of hereditary amyloidosis captured by massive parallel sequencing
por: Chyra Kufova, Zuzana, et al.
Publicado: (2018)

Mesenchymal stromal cells as carriers of IL-12 reduce primary and metastatic tumors of murine melanoma
por: Kułach, Natalia, et al.
Publicado: (2021)

M1-like macrophages change tumor blood vessels and microenvironment in murine melanoma
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2018)

Tumor Microenvironment as A “Game Changer” in Cancer Radiotherapy
por: Jarosz-Biej, Magdalena, et al.
Publicado: (2019)

Heterogenous mutation spectrum and deregulated cellular pathways in aberrant plasma cells underline molecular pathology of light-chain amyloidosis
por: Chyra, Zuzana, et al.
Publicado: (2020)

Use of CRRT-CVVH in a hemato-oncological ICU in patients treated with defibrotide for veno-occlusive disease in patients after allogeneic hematopoetic stem cell transplantation: single-center experience
por: Navratil, M, et al.
Publicado: (2010)

Prognostic Significance of STING Immunoexpression in Relation to HPV16 Infection in Patients with Squamous Cell Carcinomas of Oral Cavity and Oropharynx
por: Biesaga, Beata, et al.
Publicado: (2022)

The effect of culture media on large-scale expansion and characteristic of adipose tissue-derived mesenchymal stromal cells
por: Czapla, Justyna, et al.
Publicado: (2019)

Characteristic of c-Kit(+) progenitor cells in explanted human hearts
por: Matuszczak, Sybilla, et al.
Publicado: (2014)

D-K(6)L(9) Peptide Combination with IL-12 Inhibits the Recurrence of Tumors in Mice
por: Cichoń, Tomasz, et al.
Publicado: (2014)

Human Cardiac Mesenchymal Stromal Cells with CD105(+)CD34(-) Phenotype Enhance the Function of Post-Infarction Heart in Mice
por: Czapla, Justyna, et al.
Publicado: (2016)

Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
por: Smolarczyk, Ryszard, et al.
Publicado: (2018)

Author Correction: Combination of anti-vascular agent - DMXAA and HIF-1α inhibitor - digoxin inhibits the growth of melanoma tumors
por: Smolarczyk, Ryszard, et al.
Publicado: (2020)

Antitumor Effects of Recombinant Antivascular Protein ABRaA-VEGF(121) Combined with IL-12 Gene Therapy
por: Ciomber, Agnieszka, et al.
Publicado: (2013)

Hydrophilic Copolymers with Hydroxamic Acid Groups as a Protective Biocompatible Coating of Maghemite Nanoparticles: Synthesis, Physico-Chemical Characterization and MRI Biodistribution Study
por: Charvátová, Hana, et al.
Publicado: (2023)

Monitoring of diffusion properties and transverse relaxation time of mouse ischaemic muscle after administration of human mesenchymal stromal cells derived from adipose tissue
por: Skorupa, Agnieszka, et al.
Publicado: (2019)

Involvement of Small Non-Coding RNA and Cell Antigens in Pathogenesis of Extramedullary Multiple Myeloma
por: Vlachová, Monika, et al.
Publicado: (2022)

TGF-β – an excellent servant but a bad master
por: Kubiczkova, Lenka, et al.
Publicado: (2012)

Effects of Epigallocatechin Gallate on Tert-Butyl Hydroperoxide-Induced Mitochondrial Dysfunction in Rat Liver Mitochondria and Hepatocytes
por: Mezera, Vojtech, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ni3mro4peegvcu1b9guqhbhfeq